Today: Stifel Nicolaus Cuts Medtronic PLC (MDT) Price Target to $81.00

Today: Stifel Nicolaus Cuts Medtronic PLC (MDT) Price Target to $81.00

Medtronic PLC (NYSE:MDT) had its price target decreased by Stifel Nicolaus from $91.00 to $81.00 in a research report report published on Wednesday. Stifel Nicolaus currently has a hold rating on the medical technology company’s stock.

Several other equities analysts also recently commented on MDT. Needham & Company LLC boosted their price target on shares of Medtronic PLC from $93.00 to $95.00 and gave the stock a buy rating in a research note on Thursday, August 25th. Vetr downgraded shares of Medtronic PLC from a strong-buy rating to a buy rating and set a $91.28 price target for the company. in a research note on Monday, November 21st. Jefferies Group restated a buy rating and issued a $93.00 price target on shares of Medtronic PLC in a research note on Thursday, August 25th. Cowen and Company set a $94.00 price target on shares of Medtronic PLC and gave the stock a buy rating in a research note on Tuesday, August 23rd. Finally, Credit Suisse Group AG restated an outperform rating and issued a $92.00 price target on shares of Medtronic PLC in a research note on Thursday, August 25th. Seven investment analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the stock. Medtronic PLC has an average rating of Buy and an average target price of $88.47.

Medtronic PLC (NYSE:MDT) opened at 75.52 on Wednesday. The company has a 50-day moving average price of $81.84 and a 200-day moving average price of $84.68. The stock has a market cap of $104.36 billion, a price-to-earnings ratio of 29.39 and a beta of 1.01. Medtronic PLC has a 52 week low of $71.03 and a 52 week high of $89.27.

Medtronic PLC (NYSE:MDT) last posted its earnings results on Tuesday, November 22nd. The medical technology company reported $1.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.11 by $0.01. Medtronic PLC had a net margin of 14.63% and a return on equity of 12.36%. The firm earned $7.35 billion during the quarter, compared to the consensus estimate of $7.46 billion. During the same quarter last year, the firm earned $1.03 EPS. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. Equities research analysts anticipate that Medtronic PLC will post $4.63 EPS for the current year.

In other Medtronic PLC news, VP Richard Kuntz sold 25,199 shares of the stock in a transaction that occurred on Monday, September 26th. The shares were sold at an average price of $86.67, for a total transaction of $2,183,997.33. Following the transaction, the vice president now owns 149,425 shares of the company’s stock, valued at $12,950,664.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director James T. Lenehan purchased 2,000 shares of the business’s stock in a transaction on Wednesday, November 23rd. The shares were bought at an average cost of $73.27 per share, for a total transaction of $146,540.00. The disclosure for this purchase can be found here. Company insiders own 0.25% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. Krilogy Financial LLC increased its position in shares of Medtronic PLC by 35.2% in the second quarter. Krilogy Financial LLC now owns 1,163 shares of the medical technology company’s stock worth $101,000 after buying an additional 303 shares in the last quarter. Motco increased its position in shares of Medtronic PLC by 70.9% in the third quarter. Motco now owns 1,350 shares of the medical technology company’s stock worth $117,000 after buying an additional 560 shares in the last quarter. TLP Group LLC acquired a new position in shares of Medtronic PLC during the third quarter worth approximately $124,000. Birch Hill Investment Advisors LLC acquired a new position in shares of Medtronic PLC during the third quarter worth approximately $128,000. Finally, Proficio Capital Partners LLC increased its position in shares of Medtronic PLC by 0.5% in the third quarter. Proficio Capital Partners LLC now owns 1,505 shares of the medical technology company’s stock worth $130,000 after buying an additional 8 shares in the last quarter. 80.95% of the stock is currently owned by institutional investors and hedge funds.

Medtronic PLC Company Profile

Related posts

Leave a Comment